canrenoic acid has been researched along with Heart Failure in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Dąbrowski, R; Farkowski, M; Hryniewiecki, T; Kowalik, I; Kubaszek-Kornatowska, A; Mączyńska, J; Michałek, P; Sawicki, S; Syska, P; Szwed, H | 1 |
| Berger, C; Berthiller, J; Bochaton, T; Bonnefoy-Cudraz, E; Luyt, CE; Prieur, C | 1 |
| Aubry, M; Girerd, N; Huttin, O; Lantelme, P; Rossignol, P | 1 |
| Coppi, F; Crupi, N; Monopoli, D; Rossi, R; Sgura, F | 1 |
| Charles, CJ; Nicholls, MG; Rademaker, MT; Richards, AM | 1 |
| Collier, PS; Halliday, HL; Hawwa, AF; Kole, P; McElnay, JC; Millar, M; Millership, JS; Shields, MD; Suyagh, M | 1 |
| Belle, L; Beygui, F; Cayla, G; Collet, JP; Cornillet, L; Delarche, N; Ecollan, P; Furber, A; Galinier, M; Goldstein, P; Lebon, A; Legallois, D; Machecourt, J; Montalescot, G; Motreff, P; Roubille, F; Roule, V; Rousseau, H; Silvain, J; Van Belle, E; Vicaut, E; Zannad, F | 1 |
| Bos, R; Findji, L; Lechat, P; Médiani, O; Mougenot, N; Vanhoutte, PM | 1 |
| Beugels, IP; Cohuet, GM; de Gooyer, ME; Emmen, JM; Hermans, JJ; Hilbers, PA; Minnaard-Huiban, M; Ottenheijm, HC; Pieterse, K; Plate, R; Roumen, L; Ruijters, E; Smits, JF; van Essen, H | 1 |
| Budaj, A; Ceremuzyński, L; Michorowski, B | 1 |
| Osswald, H | 1 |
| Bräuninger, HJ; Gorbach, HC | 1 |
| Lüderitz, B; Naumann d'Alnoncourt, C; Steinbeck, G | 1 |
| Ciaccio, S; Coltorti, M; Corsini, R; Radaeli, E; Trebbi, R | 1 |
| Kirsch, R | 1 |
| Lant, A | 1 |
1 review(s) available for canrenoic acid and Heart Failure
| Article | Year |
|---|---|
Diuretics. Clinical pharmacology and therapeutic use (Part II).
Topics: Amiloride; Canrenoic Acid; Diuretics; Diuretics, Osmotic; Drug Interactions; Hearing Disorders; Heart Failure; Humans; Hypertension; Hypokalemia; Indans; Kidney Failure, Chronic; Liver Diseases; Potassium; Pulmonary Edema; Spironolactone; Ticrynafen; Triamterene; Uricosuric Agents; Water-Electrolyte Imbalance; Xanthines | 1985 |
2 trial(s) available for canrenoic acid and Heart Failure
| Article | Year |
|---|---|
Clinical efficacy of potassium canreonate-canrenone in sinus rhythm restoration among patients with atrial fibrillation - a protocol of a pilot, randomized, double -blind, placebo-controlled study (CANREN-AF trial).
Topics: Administration, Intravenous; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Canrenoic Acid; Case-Control Studies; Double-Blind Method; Electric Countershock; Electrocardiography; Heart Failure; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Placebos; Potassium; Renin-Angiotensin System; Safety; Sinoatrial Node; Treatment Outcome | 2020 |
Early Aldosterone Blockade in Acute Myocardial Infarction: The ALBATROSS Randomized Clinical Trial.
Topics: Age Factors; Aged; Canrenoic Acid; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Proportional Hazards Models; Risk Assessment; Severity of Illness Index; Sex Factors; Single-Blind Method; Spironolactone; Statistics, Nonparametric; Survival Analysis; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2016 |
13 other study(ies) available for canrenoic acid and Heart Failure
| Article | Year |
|---|---|
Patients with acute heart failure treated with the CARRESS-HF diuretic protocol in association with canrenoate potassium: Tolerance of high doses of canrenoate potassium.
Topics: Acute Disease; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Canrenoic Acid; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Retrospective Studies; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Treatment Outcome | 2020 |
Intravenous Mineralocorticoid Receptor Antagonist Use in Acutely Decompensated Heart Failure with Diuretic Resistance.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Bumetanide; Canrenoic Acid; Creatinine; Diuresis; Diuretics; Drug Combinations; Drug Resistance; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Male; Mineralocorticoid Receptor Antagonists; Potassium; Treatment Outcome | 2021 |
Importance of the time of initiation of mineralocorticoid receptor antagonists on risk of mortality in patients with heart failure.
Topics: Adult; Aged; Aged, 80 and over; Canrenoic Acid; Cohort Studies; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Prognosis; Spironolactone; Survival Analysis; Treatment Outcome | 2015 |
Interactions of enhanced urocortin 2 and mineralocorticoid receptor antagonism in experimental heart failure.
Topics: Animals; Canrenoic Acid; Cardiac Pacing, Artificial; Drug Interactions; Epinephrine; Female; Heart Failure; Hemodynamics; Hydrocortisone; Mineralocorticoid Receptor Antagonists; Norepinephrine; Potassium; Renin-Angiotensin System; Sheep; Sodium; Urocortins | 2013 |
Potassium canrenoate treatment in paediatric patients: a population pharmacokinetic study using novel dried blood spot sampling.
Topics: Administration, Intravenous; Body Weight; Canrenoic Acid; Computer Simulation; Dried Blood Spot Testing; Drug Administration Schedule; Female; Gestational Age; Heart Failure; Humans; Infant; Infant, Newborn; Lung Diseases; Male; Prospective Studies; Treatment Outcome | 2013 |
Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist.
Topics: Adrenergic beta-Agonists; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Canrenoic Acid; Fibrosis; Heart Failure; Isoproterenol; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptors, Adrenergic, beta | 2005 |
Fadrozole reverses cardiac fibrosis in spontaneously hypertensive heart failure rats: discordant enantioselectivity versus reduction of plasma aldosterone.
Topics: Aldosterone; Animals; Canrenoic Acid; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Drug Evaluation, Preclinical; Fadrozole; Fibrosis; Gene Expression Regulation; Heart; Heart Failure; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Inbred SHR; Stereoisomerism; Structure-Activity Relationship; Treatment Outcome | 2008 |
Single-dose i.v. Aldactone for congestive heart failure: a preliminary observation.
Topics: Aged; Aldosterone; Canrenoic Acid; Diuresis; Female; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Pregnadienes; Time Factors | 1983 |
[Aldosterone antagonists in coronary insufficiency].
Topics: Arrhythmias, Cardiac; Canrenoic Acid; Heart Failure; Humans; Myocardial Contraction; Myocardial Infarction; Pregnadienes; Spironolactone; Stimulation, Chemical | 1978 |
[Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
Topics: Administration, Oral; Aged; Blood Pressure; Body Weight; Canrenoic Acid; Female; Heart Failure; Humans; Hyperaldosteronism; Injections; Liver Cirrhosis; Male; Natriuresis; Potassium; Pregnadienes; Sodium; Spironolactone | 1975 |
Effects of antikaliuretic agents on cardiac electrophysiology--measurements in papillary heart muscle and in purkinje fibers.
Topics: Action Potentials; Amiloride; Animals; Canrenoic Acid; Cardiac Glycosides; Diuretics; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Guinea Pigs; Heart Conduction System; Heart Failure; Membrane Potentials; Ouabain; Papillary Muscles; Purkinje Fibers; Refractory Period, Electrophysiological; Triamterene | 1977 |
[Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
Topics: Adult; Aged; Ascites; Canrenoic Acid; Drug Evaluation; Drug Therapy, Combination; Edema; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans; Hyperaldosteronism; Liver Cirrhosis; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Pregnadienes; Water-Electrolyte Imbalance | 1976 |
[Indication and experience with an intravenously administered aldosterone-antagonist (soldactone) (author's transl)].
Topics: Brain Edema; Canrenoic Acid; Drug Evaluation; Heart Failure; Humans; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Pregnadienes; Respiratory Insufficiency | 1975 |